Welcome to our dedicated page for Bakkt SEC filings (Ticker: BKKT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Bakkt, Inc. filings document the regulatory record of a public financial technology company focused on digital asset and programmable finance infrastructure. Its SEC disclosures cover operating and financial results, Regulation FD materials, shareholder letters, material-event reports, and securities registered for trading, including Class A common stock and warrants.
Bakkt’s proxy and 8-K filings also address governance matters, executive compensation, shareholder voting items, share-issuance approvals, material agreements, and capital-structure actions such as an at-the-market equity program. The filing record includes notices related to annual-report timing and formal disclosures tied to special meetings, securities issuance mechanics, and public-company reporting obligations.
Bakkt, Inc. disclosed that Transchem Ltd.’s Preferential Issue Committee approved the allotment of 47,500,000 warrants to its subsidiary, Bakkt Opco Holdings, LLC. These warrants entitle the holder to acquire ordinary shares of Transchem in line with the terms of a previously approved preferential allotment.
The company paid $9,409,784 for the warrants, described as 25% of the total subscription amount, reflecting an initial cash outlay tied to this investment in the Indian-listed company Transchem.
Bakkt, Inc. is registering the offer and resale of up to 21,010,640 shares of Class A Common Stock for the selling stockholders named in the prospectus, including shares issued in connection with the DTR Acquisition, the Up-C collapse and the Gyzer acquisition. The resale is by selling stockholders in their sole discretion; the Company will receive no proceeds from resales (except potential cash proceeds if certain warrants are exercised). As of April 30, 2026, there were 47,866,956 shares outstanding. The registration implements contractual registration rights granted in connection with the DTR Acquisition and related agreements.
Bakkt, Inc. Chief Operating Officer Nicholas Baes exercised stock options to acquire 671 shares of Class A Common Stock at $10.00 per share. After the transaction, he directly holds 106,937 Class A shares, including 69,988 shares subject to unvested RSU awards, and 52,349 stock options remain outstanding under the referenced option grant.
Bakkt, Inc.’s Chief Financial Officer Alexander Karen exercised stock options to acquire 335 shares of Class A common stock at $10.00 per share on May 15, 2026. After the exercise, he directly holds 56,106 shares, including 18,852 shares subject to restricted and performance stock units that still must vest.
The options exercised are part of a grant that requires a predetermined number of options to be exercised each quarter over eight quarters at $10.00 per share, with each quarterly tranche exercisable only during a defined two-day exercise period, subject to blackout-period adjustments.
Bakkt, Inc. General Counsel & Secretary Marc D'Annunzio exercised stock options for 1,677 shares of Class A common stock at $10.00 per share. After the transaction, he directly holds 111,736 common shares, which include 14,861 shares tied to restricted and performance stock unit awards that are still subject to vesting.
Bakkt, Inc. director Michael Alfred reported indirect open-market purchases of a total of 585,000 shares of Class A Common Stock through Alpine Fox LP at weighted-average prices of about $8.20 and $8.34 per share on May 15 and May 18, 2026. Following these transactions, Alpine Fox LP holds 625,000 shares indirectly, and Alfred also has 28,476 directly held shares subject to RSUs that remain subject to vesting.
Bakkt, Inc. Chief Executive Officer Akshay Sudhir Naheta exercised stock options to acquire 33,557 shares of Class A Common Stock at an exercise price of $10.00 per share. Following this transaction, he directly holds 9,093,522 shares of Class A Common Stock.
The exercised options were part of a larger option grant, and 1,275,168 stock options remain outstanding after the exercise. His equity position also includes 803,861 Performance Stock Units that are still subject to vesting conditions, indicating that most of his overall equity exposure remains unchanged.
Bakkt, Inc. ownership disclosure: Alyeska Investment Group and affiliated persons beneficially own 3,053,153 shares of Class A common stock, representing 9.99% of the class as of March 31, 2026. The position comprises 1,023,810 currently held shares and 2,029,343 shares issuable upon exercise of pre-funded warrants constrained by a 9.99% beneficial ownership limitation. The filing cites 30,562,096 shares outstanding per the Form 10-K dated March 19, 2026. The filing states Alyeska Investment Group exercises voting and investment control for Alyeska Master Fund, L.P., and that Anand Parekh may be deemed a beneficial owner (with a disclaimer).
Bakkt, Inc. is registering for resale up to 21,010,640 shares of Class A Common Stock held by various selling stockholders, including shares issued in connection with the DTR Acquisition, the Up-C collapse and the Gyzer acquisition. The registration is to satisfy contractual registration rights and does not involve the company selling shares; proceeds from resales will be received by the selling stockholders.
The company may receive proceeds only if certain warrants are exercised for cash: up to $11,764,680 from ICE warrants and up to $2,500,000 from Gyzer Acquisition Warrants. Shares outstanding were 47,866,956 as of April 30, 2026.